secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2026-08-05T11:03:20+00:00
Accession:  0001193125-26-333817
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix Q2 net sales $210.9M (+5% constant currency); raises FY2026 guidance
-----------------------------------------------------------------------------

- Q2 net sales $210.9M, up 5% pro forma constant currency YoY; GAAP net loss $(15.8)M ($0.39 loss per share).
- Non-GAAP adjusted EBITDA $20.1M (9.6% of sales) vs $20.6M (10.3%) prior year; margin slightly down.
- Raised FY2026 net sales guidance to $845M-$855M (from $838M-$848M) and adjusted EBITDA to $95M-$98M (from $90M-$93M).
- Global Limb Reconstruction grew 11% constant currency; Spine Fixation double-digit; Biologics stabilizing.
- Cash $104.4M, down from $120.9M due to arbitration payments to former executives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000119312526333817/0001193125-26-333817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000119312526333817/ofix-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-333817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer